Autres langues Structure Therapeutics Inc.

Actions

GPCR

US86366E1064

Temps réel estimé Cboe BZX Autres places de cotation 20:50:21 24/05/2024			Varia. 5j.	Varia. 1 janv.
37,05 ^USD	-3,31%		+3,21%	-8,46%

21/05	STRUCTURE THERAPEUTICS INC. : JPMorgan Chase réitère son opinion positive sur le titre	ZM
09/05	Structure Therapeutics Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights	09/05
ADRs Edge Higher; Lufax Climbs Almost 46%	21/03
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference	11/03
Structure Therapeutics to Present at Leerink Partners Global Biopharma Conference	08/03
Structure Therapeutics Q4 Loss Widens	08/03
Structure Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/03
Structure Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/03
Structure Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Highlights	08/03
Health Care Down on Growth Bias -- Health Care Roundup	19/12
ADRs Advance, Fanhua Inc. Climbs 26.7%	18/12
Structure Therapeutics Shares Tumble After Update on GSBR-1290 for Weight Loss	18/12
Structure's diabetes pill misses weight-loss expectations in mid-stage trial	18/12
Structure Therapeutics Inc. Provides Comprehensive GSBR-1290 Program Update	18/12
Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study	18/12
Structure Therapeutics Provides Comprehensive GSBR-1290 Program Update Including Clinically Meaningful Proof-of-Concept Data From Phase 2a Clinical Study	18/12
Structure Therapeutics Inc.(NasdaqGM:GPCR) added to NASDAQ Biotechnology Index	18/12
ADRs Slump; FLJ Group Ltd. Declines 13.7%	15/11
Structure Therapeutics Q3 Loss Narrows	14/11
Structure Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Structure Therapeutics Inc.

Actions

GPCR

US86366E1064

Autres langues

Filtres